Page 55 - Mobile Android News Today

Steven A. Rosenberg, MD, PhD, FAACR, will receive this year’s Pezcoller Foundation-American Association of Cancer Research International Award for Extraordinary Achievement in Cancer Research.The award recognizes a scientist who has made a major scientific discovery in basic or translational cancer research, remains active in cancer research, and is conducting ongoing work that offers

In patients with ACS, the PCSK9 inhibitor alirocumab did not impact the development of atrial fibrillation compared with placebo, according to new data from the ODYSSEY Outcomes trial.While history of AF conferred greater risk for major adverse CV events during follow-up, the risk did not vary by assignment to alirocumab (Praluent, Sanofi/Regeneron) or placebo, according to the researchers.

Krishna Komanduri, MD, has been appointed division chief of hematology-oncology at UCSF Health.Komanduri, recognized for his expertise in the fields of cellular immunotherapy and transplantation, also will serve as physician-in-chief of Helen Diller Family Comprehensive Cancer Center and clinical director of UCSF Living Therapeutics Initiative.

CHICAGO — Despite a reduction in pediatric patients presenting with orthopedic injuries during the COVID-19 pandemic, results showed these patients had an increase in polytrauma requiring more procedures and worse hospital outcomes.

The combination of MDMA and psychotherapy improved PTSD symptoms among participants in a phase 3 clinical trial, researchers reported at the spring meeting of the American Chemical Society. Preliminary findings suggest that the combination works in hard-to-treat patients, including those with drug or alcohol use disorders, Jennifer Mitchell, PhD, principal investigator and professor of neurology

Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, according to randomized phase 3 trial results presented at Society of Gynecologic Oncology 2022 Annual Meeting on Women's Cancer.“The minimally invasive surgical approach had worse DFS compared with the open approach, and we confirmed this after median follow up of 4.5 years for all

BOSTON — Long-term use of tralokinumab showed sustained atopic dermatitis improvement with no new safety signals, according to a poster presented at the American Academy of Dermatology Annual Meeting. “These results represent the longest treatment period reported to date for any selective [interleukin (IL)]-13 inhibitor,” Andrew Blauvelt, MD, president of Oregon Medical Research

BOSTON — A rapid improvement in severe acne was observed in patients treated with 12 weeks of trifarotene and doxycycline, according to a poster presented at the American Academy of Dermatology Annual Meeting. “Both the physical and psychological impact of acne increase with increasing disease severity,” James Del Rosso, DO, of JDR Dermatology in Las Vegas, and colleagues wrote.

DENVER — Mental health disability identity relies on factors such as health prioritization, willingness for disclosure and need for integration, a speaker said at the Anxiety and Depression Association of America annual conference.“The degree to which people identify with a mental health diagnosis is an understudied section of the field. We are seeking to fill that gap,” Emily

NASHVILLE, Tenn. — Patients with glaucoma who underwent trabeculectomy or tube shunt surgery had similar rates of reoperation and similar surgical outcomes regardless of initial procedure, according to a study.